1. Home
  2. CYTK vs IPAR Comparison

CYTK vs IPAR Comparison

Compare CYTK & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • IPAR
  • Stock Information
  • Founded
  • CYTK 1997
  • IPAR 1982
  • Country
  • CYTK United States
  • IPAR United States
  • Employees
  • CYTK N/A
  • IPAR N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • IPAR Package Goods/Cosmetics
  • Sector
  • CYTK Health Care
  • IPAR Consumer Discretionary
  • Exchange
  • CYTK Nasdaq
  • IPAR Nasdaq
  • Market Cap
  • CYTK 4.6B
  • IPAR 3.9B
  • IPO Year
  • CYTK 2004
  • IPAR 1988
  • Fundamental
  • Price
  • CYTK $53.01
  • IPAR $113.10
  • Analyst Decision
  • CYTK Buy
  • IPAR Strong Buy
  • Analyst Count
  • CYTK 15
  • IPAR 4
  • Target Price
  • CYTK $75.57
  • IPAR $162.00
  • AVG Volume (30 Days)
  • CYTK 2.6M
  • IPAR 214.6K
  • Earning Date
  • CYTK 11-05-2025
  • IPAR 11-05-2025
  • Dividend Yield
  • CYTK N/A
  • IPAR 2.83%
  • EPS Growth
  • CYTK N/A
  • IPAR 14.29
  • EPS
  • CYTK N/A
  • IPAR 5.02
  • Revenue
  • CYTK $85,738,000.00
  • IPAR $1,458,888,000.00
  • Revenue This Year
  • CYTK $330.96
  • IPAR $5.62
  • Revenue Next Year
  • CYTK $73.41
  • IPAR $4.30
  • P/E Ratio
  • CYTK N/A
  • IPAR $22.49
  • Revenue Growth
  • CYTK 2635.74
  • IPAR 7.04
  • 52 Week Low
  • CYTK $29.31
  • IPAR $97.65
  • 52 Week High
  • CYTK $59.39
  • IPAR $148.15
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 77.96
  • IPAR 40.03
  • Support Level
  • CYTK $35.22
  • IPAR $112.26
  • Resistance Level
  • CYTK $50.22
  • IPAR $116.05
  • Average True Range (ATR)
  • CYTK 2.29
  • IPAR 2.72
  • MACD
  • CYTK 1.64
  • IPAR 0.49
  • Stochastic Oscillator
  • CYTK 94.73
  • IPAR 36.32

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About IPAR Inter Parfums Inc.

Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.

Share on Social Networks: